{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:17:38Z","timestamp":1794939458610,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Drug Discov."],"DOI":"10.1038\/s44386-026-00067-0","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:54:39Z","timestamp":1788339279000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pushing the boundaries of virtual screening scale of combinatorial spaces with the V-SYNTHES approach"],"prefix":"10.1038","volume":"3","author":[{"given":"Mykola","family":"Protopopov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olha","family":"Semenenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryna","family":"Vasylchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasiia V.","family":"Sadybekov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arman A.","family":"Sadybekov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateryna","family":"Horbatok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksii","family":"Hrabovskyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kapeliukha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina","family":"Nazarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmytro","family":"Radchenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vsevolod","family":"Katritch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Tarkhanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"67_CR1","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1021\/jacs.1c08402","volume":"144","author":"A Luttens","year":"2022","unstructured":"Luttens, A. et al. Ultralarge virtual screening identifies SARS-CoV-2 main protease inhibitors with broad-spectrum activity against coronaviruses. J. Am. Chem. Soc. 144, 2905\u20132920 (2022).","journal-title":"J. Am. Chem. Soc."},{"key":"67_CR2","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41586-019-0917-9","volume":"566","author":"J Lyu","year":"2019","unstructured":"Lyu, J. et al. Ultra-large library docking for discovering new chemotypes. Nature 566, 224\u2013229 (2019).","journal-title":"Nature"},{"key":"67_CR3","doi-asserted-by":"publisher","first-page":"102829","DOI":"10.1016\/j.sbi.2024.102829","volume":"87","author":"J Carlsson","year":"2024","unstructured":"Carlsson, J. & Luttens, A. Structure-based virtual screening of vast chemical space as a starting point for drug discovery. Curr. Opin. Struct. Biol. 87, 102829 (2024).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"67_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41586-020-2027-0","volume":"579","author":"RM Stein","year":"2020","unstructured":"Stein, R. M. et al. Virtual discovery of melatonin receptor ligands to modulate circadian rhythms. Nature 579, 609\u2013614 (2020).","journal-title":"Nature"},{"key":"67_CR5","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-020-2117-z","volume":"580","author":"C Gorgulla","year":"2020","unstructured":"Gorgulla, C. et al. An open-source drug discovery platform enables ultra-large virtual screens. Nature 580, 663\u2013668 (2020).","journal-title":"Nature"},{"key":"67_CR6","unstructured":"McGann, M. OpenEye Scientific. GigaDocking\u2014Structure Based Virtual Screening of Over 1 Billion Molecules Webinar https:\/\/www.eyesopen.com\/webinars\/giga-docking-structure-based-virtual-screening."},{"key":"67_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-023-05905-z","volume":"616","author":"AV Sadybekov","year":"2023","unstructured":"Sadybekov, A. V. & Katritch, V. Computational approaches streamlining drug discovery. Nature 616, 673\u2013685 (2023).","journal-title":"Nature"},{"key":"67_CR8","unstructured":"Enamine REAL Space. https:\/\/enamine.net\/compound-collections\/real-compounds\/real-space-navigator."},{"key":"67_CR9","doi-asserted-by":"publisher","first-page":"10338","DOI":"10.1021\/acs.jcim.5c01912","volume":"65","author":"A Kapeliukha","year":"2025","unstructured":"Kapeliukha, A. et al. Freedom Space 3.0: ML-assisted selection of synthetically accessible small molecules. J. Chem. Inf. Model. 65, 10338\u201310347 (2025).","journal-title":"J. Chem. Inf. Model."},{"key":"67_CR10","doi-asserted-by":"publisher","first-page":"102578","DOI":"10.1016\/j.sbi.2023.102578","volume":"80","author":"M Korn","year":"2023","unstructured":"Korn, M., Ehrt, C., Ruggiu, F., Gastreich, M. & Rarey, M. Navigating large chemical spaces in early-phase drug discovery. Curr. Opin. Struct. Biol. 80, 102578 (2023).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"67_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101681","volume":"23","author":"OO Grygorenko","year":"2020","unstructured":"Grygorenko, O. O. et al. Generating multibillion chemical space of readily accessible screening compounds. iScience 23, 101681 (2020).","journal-title":"iScience"},{"key":"67_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/d41586-019-00145-6","volume":"566","author":"DE Gloriam","year":"2019","unstructured":"Gloriam, D. E. Bigger is better in virtual drug screens. Nature 566, 193\u2013194 (2019).","journal-title":"Nature"},{"key":"67_CR13","doi-asserted-by":"publisher","DOI":"10.1126\/science.ado1868","volume":"385","author":"F Liu","year":"2024","unstructured":"Liu, F. et al. Large library docking identifies positive allosteric modulators of the calcium-sensing receptor. Science 385, eado1868 (2024).","journal-title":"Science"},{"key":"67_CR14","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41586-021-04220-9","volume":"601","author":"AA Sadybekov","year":"2022","unstructured":"Sadybekov, A. A. et al. Synthon-based ligand discovery in virtual libraries of over 11 billion compounds. Nature 601, 452\u2013459 (2022).","journal-title":"Nature"},{"key":"67_CR15","unstructured":"CACHE Challenge\u2014Critical Assessment of Computational Hit-Finding Experiments. https:\/\/cache-challenge.org\/."},{"key":"67_CR16","doi-asserted-by":"publisher","first-page":"8521","DOI":"10.1021\/acs.jcim.4c01267","volume":"64","author":"F Li","year":"2024","unstructured":"Li, F. et al. CACHE Challenge #1: targeting the WDR domain of LRRK2, a Parkinson\u2019s disease associated protein. J. Chem. Inf. Model. 64, 8521\u20138536 (2024).","journal-title":"J. Chem. Inf. Model."},{"key":"67_CR17","doi-asserted-by":"publisher","first-page":"6884","DOI":"10.1021\/acs.jcim.5c00535","volume":"65","author":"O Herasymenko","year":"2025","unstructured":"Herasymenko, O. et al. CACHE Challenge #2: targeting the RNA site of the SARS-CoV-2 helicase Nsp13. J. Chem. Inf. Model. 65, 6884\u20136898 (2025).","journal-title":"J. Chem. Inf. Model."},{"key":"67_CR18","unstructured":"Herasymenko, O. et al. CACHE Challenge #3: targeting the Nsp3 macrodomain of SARS-CoV-2. J. Chem. Inf. Model. 66, 1566\u20131581 (2026)."},{"key":"67_CR19","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1038\/s41589-022-01234-w","volume":"19","author":"J Lyu","year":"2023","unstructured":"Lyu, J., Irwin, J. J. & Shoichet, B. K. Modeling the expansion of virtual screening libraries. Nat. Chem. Biol. 19, 712\u2013718 (2023).","journal-title":"Nat. Chem. Biol."},{"key":"67_CR20","doi-asserted-by":"publisher","first-page":"4274","DOI":"10.1021\/acs.jcim.9b00779","volume":"60","author":"C Grebner","year":"2020","unstructured":"Grebner, C. et al. Virtual screening in the cloud: how big is big enough? J. Chem. Inf. Model. 60, 4274\u20134282 (2020).","journal-title":"J. Chem. Inf. Model."},{"key":"67_CR21","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/s41589-024-01797-w","volume":"21","author":"F Liu","year":"2025","unstructured":"Liu, F. et al. The impact of library size and scale of testing on virtual screening. Nat. Chem. Biol. 21, 1039\u20131045 (2025).","journal-title":"Nat. Chem. Biol."},{"key":"67_CR22","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1021\/acs.jctc.0c01006","volume":"17","author":"D Santos-Martins","year":"2021","unstructured":"Santos-Martins, D. et al. Accelerating AutoDock4 with GPUs and gradient-based local search. J. Chem. Theory Comput. 17, 1060\u20131073 (2021).","journal-title":"J. Chem. Theory Comput."},{"key":"67_CR23","unstructured":"Molsoft. GigaScreen\u2014Deep Learning Approach for Screening Ultra Large Databases. https:\/\/www.molsoft.com\/GigaScreen.html."},{"key":"67_CR24","doi-asserted-by":"publisher","unstructured":"Cecchini, D. et al. AI-enhanced adaptive virtual screening platform enabling exploration of 69 billion molecules discovers structurally validated FSP1 inhibitors. Preprint at https:\/\/doi.org\/10.1101\/2023.04.25.537981 (2026).","DOI":"10.1101\/2023.04.25.537981"},{"key":"67_CR25","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s43588-025-00777-x","volume":"5","author":"A Luttens","year":"2025","unstructured":"Luttens, A. et al. Rapid traversal of vast chemical space using machine learning-guided docking screens. Nat. Comput Sci. 5, 301\u2013312 (2025).","journal-title":"Nat. Comput Sci."},{"key":"67_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52061-7","volume":"15","author":"G Zhou","year":"2024","unstructured":"Zhou, G. et al. An artificial intelligence accelerated virtual screening platform for drug discovery. Nat. Commun. 15, 7761 (2024).","journal-title":"Nat. Commun."},{"key":"67_CR27","doi-asserted-by":"crossref","unstructured":"Zhou, G. OpenVS for an artificial intelligence accelerated virtual screening platform for drug discovery. https:\/\/github.com\/gfzhou\/OpenVS (2024).","DOI":"10.1038\/s41467-024-52061-7"},{"key":"67_CR28","doi-asserted-by":"publisher","unstructured":"Corso, G., St\u00e4rk, H., Jing, B., Barzilay, R. & Jaakkola, T. DiffDock: diffusion steps, twists, and turns for molecular docking. Preprint at https:\/\/doi.org\/10.48550\/ARXIV.2210.01776 (2022).","DOI":"10.48550\/ARXIV.2210.01776"},{"key":"67_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500 (2024).","journal-title":"Nature"},{"key":"67_CR30","doi-asserted-by":"publisher","unstructured":"Passaro, S. et al. Boltz-2: towards accurate and efficient binding affinity prediction. Preprint at https:\/\/doi.org\/10.1101\/2025.06.14.659707 (2025).","DOI":"10.1101\/2025.06.14.659707"},{"key":"67_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.103985","volume":"29","author":"L Wang","year":"2024","unstructured":"Wang, L. et al. The present state and challenges of active learning in drug discovery. Drug Discov. Today 29, 103985 (2024).","journal-title":"Drug Discov. Today"},{"key":"67_CR32","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s44386-026-00053-6","volume":"3","author":"AL Nazarova","year":"2026","unstructured":"Nazarova, A. L. et al. V-SYNTHES2 - the next generation tool for structure-based virtual screening of gigascale chemical spaces. npj Drug Discov. 3, 21 (2026).","journal-title":"npj Drug Discov."},{"key":"67_CR33","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s44386-025-00035-0","volume":"3","author":"AV Sadybekov","year":"2026","unstructured":"Sadybekov, A. V. et al. Development of potent, selective cPLA2 inhibitors for targeting neuroinflammation in Alzheimer\u2019s disease and other neurodegenerative disorders. npj Drug Discov. 3, 2 (2026).","journal-title":"npj Drug Discov."},{"key":"67_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.peptides.2023.171137","volume":"172","author":"IM Souza-Silva","year":"2024","unstructured":"Souza-Silva, I. M. et al. Development of an automated, high-throughput assay to detect angiotensin AT2-receptor agonistic compounds by nitric oxide measurements in vitro. Peptides 172, 171137 (2024).","journal-title":"Peptides"},{"key":"67_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33981-8","volume":"13","author":"P Beroza","year":"2022","unstructured":"Beroza, P. et al. Chemical space docking enables large-scale structure-based virtual screening to discover ROCK1 kinase inhibitors. Nat. Commun. 13, 6447 (2022).","journal-title":"Nat. Commun."},{"key":"67_CR36","doi-asserted-by":"publisher","first-page":"7569","DOI":"10.1021\/acs.jcim.5c00222","volume":"65","author":"B Medel-Lacruz","year":"2025","unstructured":"Medel-Lacruz, B. et al. Synthon-based strategies exploiting molecular similarity and protein\u2013ligand interactions for efficient screening of ultra-large chemical libraries. J. Chem. Inf. Model. 65, 7569\u20137583 (2025).","journal-title":"J. Chem. Inf. Model."},{"key":"67_CR37","doi-asserted-by":"publisher","first-page":"e36521","DOI":"10.1371\/journal.pone.0036521","volume":"7","author":"AO Adedeji","year":"2012","unstructured":"Adedeji, A. O. et al. Mechanism of nucleic acid unwinding by SARS-CoV helicase. PLoS ONE 7, e36521 (2012).","journal-title":"PLoS ONE"},{"key":"67_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25166-6","volume":"12","author":"JA Newman","year":"2021","unstructured":"Newman, J. A. et al. Structure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase. Nat. Commun. 12, 4848 (2021).","journal-title":"Nat. Commun."},{"key":"67_CR39","doi-asserted-by":"crossref","unstructured":"Katritch, V., Rueda, M. & Abagyan, R. Ligand-guided receptor optimization. in Homology Modeling Vol. 857 (eds Orry, A. J. W. & Abagyan, R.) 189\u2013205 (Humana Press, 2011).","DOI":"10.1007\/978-1-61779-588-6_8"},{"key":"67_CR40","doi-asserted-by":"publisher","first-page":"5896","DOI":"10.1021\/acs.jcim.2c00790","volume":"62","author":"E Raush","year":"2022","unstructured":"Raush, E., Abagyan, R. & Totrov, M. Graph-convolutional neural net model of the statistical torsion profiles for small organic molecules. J. Chem. Inf. Model. 62, 5896\u20135906 (2022).","journal-title":"J. Chem. Inf. Model."},{"key":"67_CR41","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1021\/acsptsci.1c00253","volume":"5","author":"A Corona","year":"2022","unstructured":"Corona, A. et al. Natural compounds inhibit SARS-CoV-2 nsp13 unwinding and ATPase enzyme activities. ACS Pharmacol. Transl. Sci. 5, 226\u2013239 (2022).","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"67_CR42","doi-asserted-by":"crossref","unstructured":"Bellmann, L., Penner, P. & Rarey, M. Topological Similarity Search in Large Combinatorial Fragment Spaces. J. Chem. Inf. Model. 61, 238\u2013251 (2021).","DOI":"10.1021\/acs.jcim.0c00850"},{"key":"67_CR43","doi-asserted-by":"crossref","unstructured":"Schmidt, R., Klein, R. & Rarey, M. Maximum Common Substructure Searching in Combinatorial Make-on-Demand Compound Spaces. J. Chem. Inf. Model. 62, 2133\u20132150 (2022).","DOI":"10.1021\/acs.jcim.1c00640"},{"key":"67_CR44","doi-asserted-by":"crossref","unstructured":"Lessel, U., Wellenzohn, B., Lilienthal, M. & Claussen, H. Searching Fragment Spaces with Feature Trees. J. Chem. Inf. Model. 49, 270\u2013279 (2009).","DOI":"10.1021\/ci800272a"},{"key":"67_CR45","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/35003235","volume":"403","author":"YJ Chiang","year":"2000","unstructured":"Chiang, Y. J. et al. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403, 216\u2013220 (2000).","journal-title":"Nature"},{"key":"67_CR46","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1021\/acs.jmedchem.3c01361","volume":"67","author":"L Zhou","year":"2024","unstructured":"Zhou, L. et al. Rising star in immunotherapy: development and therapeutic potential of small-molecule inhibitors targeting casitas B cell lymphoma-b (Cbl-b). J. Med. Chem. 67, 816\u2013837 (2024).","journal-title":"J. Med. Chem."},{"key":"67_CR47","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s42003-023-05655-8","volume":"6","author":"SW Kimani","year":"2023","unstructured":"Kimani, S. W. et al. The co-crystal structure of Cbl-b and a small-molecule inhibitor reveals the mechanism of Cbl-b inhibition. Commun. Biol. 6, 1272 (2023).","journal-title":"Commun. Biol."},{"key":"67_CR48","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.53779","volume":"9","author":"N Patel","year":"2020","unstructured":"Patel, N. et al. Structure-based discovery of potent and selective melatonin receptor agonists. eLife 9, e53779 (2020).","journal-title":"eLife"}],"container-title":["npj Drug Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00067-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00067-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00067-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:54:41Z","timestamp":1788339281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44386-026-00067-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["67"],"URL":"https:\/\/doi.org\/10.1038\/s44386-026-00067-0","relation":{},"ISSN":["3005-1452"],"issn-type":[{"value":"3005-1452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"3 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"34"}}